πŸ‡ΊπŸ‡Έ FDA
Patent

US 8541646

Genetically modified mice and engraftment

granted A61KA61K49/00

Quick answer

US patent 8541646 (Genetically modified mice and engraftment) held by REGENERON PHARMACEUTICALS, INC. expires Mon Sep 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Sep 24 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K49/00